HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kline Expects C&T Growth In 2011, But Consumers May Continue To Snub Lux

This article was originally published in The Rose Sheet

Executive Summary

Kline & Company expects the cosmetics and toiletries market to pick up in two years; however, growth will be checked by tighter regulation and lasting consumer conservatism

You may also be interested in...



Oral Care Market Will Show Slow And Steady Growth, Packaged Facts Says

While there already is a toothbrush in every bathroom and a pack of breath-freshening gum in nearly every pocketbook, there is still room for oral care market growth, via product innovation or smart positioning and advertising, Packaged Facts says

Chattem Has High Hopes For New ACT, Selsun Launches, Raises Guidance

Chattem, unfazed by the state of the economy and supremely confident in new launches within its ACT, Gold Bond and Selsun brands, is setting its fiscal 2009 expectations at 60 cents to 75 cents per share above its 2008 guidance

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016203

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel